Cargando…
Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms
In-stent neoatherosclerosis (NA), characterized by a relatively thin fibrous cap and large volume of yellow-lipid accumulation after drug-eluting stents (DES) implantation, has attracted much attention owing to its close relationship with late complications, such as revascularization and late stent...
Autores principales: | Cui, Yuanyuan, Liu, Yue, Zhao, Fuhai, Shi, Dazhuo, Chen, Keji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944075/ https://www.ncbi.nlm.nih.gov/pubmed/27446509 http://dx.doi.org/10.1155/2016/5924234 |
Ejemplares similares
-
Association of Localized Hypersensitivity and In-Stent Neoatherosclerosis with the Very Late Drug-Eluting Stent Thrombosis
por: Yamaji, Kyohei, et al.
Publicado: (2014) -
Neoatherosclerosis in Sirolimus-Eluting Stents After Paclitaxel-Coated Ballooning Cannot Be Stabilized Despite PCSK9 Inhibitor Therapy
por: Miyoshi, Toru, et al.
Publicado: (2019) -
Prognostic Role of Fasting Remnant Cholesterol with In-Stent Restenosis After Drug-Eluting Stent Implantation
por: Luo, Yinhua, et al.
Publicado: (2022) -
Undilatable Stent Neoatherosclerosis Treated with Ad Hoc Rotational Atherectomy
por: Koutouzis, Michael, et al.
Publicado: (2017) -
The Effect of Cilostazol on Stent Thrombosis After Drug-Eluting Stent Implantation
por: Jeon, Doo-Soo, et al.
Publicado: (2010)